Prostate-specific Antigen as Surrogate for Characterizing Prostate Cancer Subgroups-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate-specific Antigen as Surrogate for Characterizing Prostate Cancer Subgroups

Published:2002-01-01 Issue:2 Volume:36 Page:106-112
ISSN:0036-5599
Container-title:Scandinavian Journal of Urology and Nephrology
language:en
Short-container-title:Scandinavian Journal of Urology and Nephrology

Author:

Sandblom G.¹,Holmberg L.²,Damber J.-E.³,Hugosson J.³,Johansson J.-E.⁴,Lundgren R.⁵,Mattsson E.²,Nilsson J.²,Varenhorst E.¹

Affiliation:

1. Department of Urology, University Hospital of Linköping, Sweden

2. Oncological Centre, Uppsala University, Sweden

3. Department of Urology, Sahlgrenska Hospital, Gothenburg, Sweden

4. Department of Urology and Centre for Assessment of Medical Technology, Örebro Medical Centre, Sweden

5. Department of Surgery/Section of Urology, Helsingborg Hospital, Sweden

Publisher

Informa UK Limited

Subject

Urology,Nephrology

Link

https://www.tandfonline.com/doi/pdf/10.1080/003655902753679382

Reference12 articles.

1. Oesterling JE, Martin SK, Bergstrahl EJ, Lowe FC. The use of prostate-speci? c antigen in staging patients with newly diagnosed prostate cancer. JAMA 1993; 269: 57.

2. Rydh A, Tomic R, Tavelin B, Hietala SO, Damber JE. Predictive value of prostate-speci? c antigen, tumour stage and tumour grade for the outcome of bone scintigraphy in patients with newly diagnosed prostate cancer. Scand J Urol Nephrol 1999; 33(2): 89-93.

3. Cohen RJ, Chan WC, Edgar SG, Robinson E, Dodd N, Hoscek S, et al. Prediction of pathological stage and clinical outcome in prostate cancer: an improved preoperative model incorporating biopsy-determined intra-ductal carcinoma. Br J Urol 1998; 81: 413-18.

4. Helgesen F, Holmberg L, Johansson JE, Bergstro¨m R, Adami HO. Trends in prostate cancer survival in Sweden 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst 1996; 88: 1216-21.

5. Gilliland FD, Hunt WC, Key CR. Improving survival for patients with prostate cancer diagnosed in the prostate-speci? c antigen era. Urology 1996; 48: 67-71.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very Long‐Term Complete Remission Can Be Achieved in Men With High‐Risk Localized Prostate Cancer and a Very High PSA Value: An Analysis of the GETUG 12 Phase 3 Trial;Clinical Genitourinary Cancer;2023-10

2. Consumption of the Whole-Grain Rye Bread and Progression of Prostate Cancer;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences;2013-11-01

3. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL;BJU International;2012-07-03

4. When to treat prostate cancer patients based on their PSA dynamics;IIE Transactions on Healthcare Systems Engineering;2012-01

5. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005;Scandinavian Journal of Urology and Nephrology;2007-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3